Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Caelyx
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Caelyx pegylated liposomal 20mg/10ml concentrate for inf
0801020K0BDAAAF
|
Caelyx | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Caelyx pegylated liposomal 50mg/25ml concentrate for inf
0801020K0BDABAG
|
Caelyx | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.